<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">4467</id>
  <title>T3D4413</title>
  <common-name>4-Hydroxyproline</common-name>
  <description>4-Hydroxyproline (or hydroxyproline or Hyp) is a major component of the protein collagen. Hydroxyproline is produced by hydroxylation of the amino acid proline and is, therefore, a post-translationally modified amino acid. Hydroxyproline and proline play key roles for collagen stability. In particular, they permit the sharp twisting of the collagen helix. Hydroxyproline is found in few proteins other than collagen. The only other mammalian protein which includes hydroxyproline is elastin. For this reason, hydroxyproline content has been used as an indicator to determine collagen and/or gelatin amount in tissue or biological samples.  Increased serum and urine levels of hydroxyproline have been found in Paget's disease  Hydroxyproline (Hyp) content in biological fluids is used as a parameter of collagen catabolism, especially bone resorption or tissue degradation. Bedridden and elderly individuals show significantly elevated serum levels of hydroxyproline in comparison to normal, active individuals  Elevated levels of urinary hydroxyproline are also indicative of muscle damage  Increased reactive oxygen species (ROS) are also known to accelerate collagen degradation. Hydroxyproline levels increase in cases of depression and stress  (A3486, A3487, A3488, A3489).</description>
  <cas>51-35-4</cas>
  <pubchem-id>5810</pubchem-id>
  <chemical-formula>C5H9NO3</chemical-formula>
  <weight>131.13</weight>
  <appearance>White powder.</appearance>
  <melting-point>274 - 275°C</melting-point>
  <boiling-point></boiling-point>
  <density nil="true"/>
  <solubility>361 mg/mL at 25°C</solubility>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity>No indication of carcinogenicity to humans (not listed by IARC).</carcinogenicity>
  <use-source>This is an endogenously produced metabolite found in the human body. It is used in metabolic reactions, catabolic reactions or waste generation.</use-source>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2014-08-29T06:51:06Z</created-at>
  <updated-at type="dateTime">2026-05-14T19:00:06Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia>Hydroxyproline</wikipedia>
  <uniprot-id nil="true"/>
  <kegg-compound-id>C01157</kegg-compound-id>
  <omim-id nil="true"/>
  <chebi-id>18095</chebi-id>
  <biocyc-id>L-4-HYDROXY-PROLINE</biocyc-id>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id>DB08847</drugbank-id>
  <pdb-id>HYP</pdb-id>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>O[C@H]1CN[C@@H](C1)C(O)=O</moldb-smiles>
  <moldb-formula>C5H9NO3</moldb-formula>
  <moldb-inchi>InChI=1S/C5H9NO3/c7-3-1-4(5(8)9)6-2-3/h3-4,6-7H,1-2H2,(H,8,9)/t3-,4+/m1/s1</moldb-inchi>
  <moldb-inchikey>PMMYEEVYMWASQN-DMTCNVIQSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">131.1299</moldb-average-mass>
  <moldb-mono-mass type="decimal">131.058243159</moldb-mono-mass>
  <origin>Endogenous</origin>
  <state>Solid</state>
  <logp>-3.17</logp>
  <hmdb-id>HMDB00725</hmdb-id>
  <chembl-id>CHEMBL352418</chembl-id>
  <chemspider-id>5605</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference>&lt;p&gt;Adams, Elijah; Goldstone, Alfred. Hydroxyproline metabolism. II. Enzymic preparation and properties of D1-pyrroline-3-hydroxy-5-carboxylic acid. Journal of Biological Chemistry (1960), 235 3492-8.&lt;/p&gt;</synthesis-reference>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM003373</chemdb-id>
  <dsstox-id>DTXSID60861573</dsstox-id>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00013764</susdat-id>
  <iupac>(2S,4R)-4-hydroxypyrrolidine-2-carboxylic acid</iupac>
  <moldb-polar-surface-area>69.56</moldb-polar-surface-area>
  <moldb-refractivity>29.3822</moldb-refractivity>
  <moldb-polarizability>12.291927113198778</moldb-polarizability>
  <moldb-rotatable-bond-count>1</moldb-rotatable-bond-count>
  <moldb-acceptor-count>4</moldb-acceptor-count>
  <moldb-donor-count>3</moldb-donor-count>
  <moldb-pka-strongest-acidic>1.6413819507648508</moldb-pka-strongest-acidic>
  <moldb-pka-strongest-basic>10.617096890348789</moldb-pka-strongest-basic>
  <moldb-physiological-charge>0</moldb-physiological-charge>
  <moldb-number-of-rings>1</moldb-number-of-rings>
  <moldb-alogps-logp>-3.31</moldb-alogps-logp>
  <moldb-alogps-logs>0.57</moldb-alogps-logs>
  <moldb-alogps-solubility>4.92e+02 g/l</moldb-alogps-solubility>
</compound>
